Scheduled Maintenance Notice

Please note that Researcher Profiles will be undergoing scheduled maintenance on Wednesday 7th Oct, from 8:00am to 9:00am. During this time, the Researcher Profiles system will be unavailable. We apologise for any inconvenience and appreciate your understanding.

Select Publications

Journal articles

Purtell L; Sze L; Loughnan GT; Smith EM; Herzog H; Sainsbury-Salis A; Steinbeck KS; Campbell LV; Viardot A, 2011, 'In adults with Prader-Willi syndrome, elevated ghrelin levels are more consistent with hyperphagia than high PYY and GLP-1 levels', Neuropeptides, 45, pp. 301 - 307, http://dx.doi.org/10.1016/j.npep.2011.06.001

Schunk E; Aigner C; Stefanova N; Wenning G; Herzog H; Schwarzer C, 2011, 'Kappa opioid receptor activation blocks progressive neurodegeneration after kainic acid injection', Hippocampus, 21, pp. 1010 - 1020, http://dx.doi.org/10.1002/hipo.20813

La Sala MS; Hurtado DM; Acosta A; Zolotukhin S; Herzog H; Dotson CD, 2011, 'Modulation of taste sensitivity and feeding by oral PYY signaling', Appetite, 57, pp. s24, http://dx.doi.org/10.1016/j.appet.2011.05.204

Nguyen AD; Herzog H; Sainsbury A, 2011, 'Neuropeptide Y and peptide YY: important regulators of energy metabolism.', Curr Opin Endocrinol Diabetes Obes, 18, pp. 56 - 60, http://dx.doi.org/10.1097/MED.0b013e3283422f0a

Tasan RO; Verma D; Mietzsch M; Weger S; Heilbronn R; Herzog H; Sperk G, 2011, 'Neuropeptide Y Y2 receptors modulate trace fear conditioning and spatial memory in the dorsal hippocampus', BMC Pharmacology, 11, pp. a2, http://dx.doi.org/10.1186/1471-2210-11-s2-a2

Yulyaningsih E; Zhang L; Herzog H; Sainsbury-Salis A, 2011, 'NPY receptors as potential targets for anti-obesity drug development', British Journal of Pharmacology, 163, pp. 1170 - 1202, http://dx.doi.org/10.1111/j.1476-5381.2011.01363.x

Verma D; Tasan RO; Mietzsch M; Weger S; Heilbronn R; Herzog H; Sperk G, 2011, 'Reduced fear conditioning after viral vector mediated neuropeptide Y administration into the basolateral amygdala', BMC Pharmacology, 11, http://dx.doi.org/10.1186/1471-2210-11-s2-a3

Zhang X; Herzog H; Song J; Wang XL; Fan C; Guo H, 2011, 'Response properties of the electrosensory neurons in hindbrain of the white sturgeon, Acipenser transmontanus', Neurosci Bull, 27, pp. 422 - 429

Acosta AC; Hurtado MD; Gorbatyuk OS; Duncan D; Aslanidi GV; Campbell-thompson ML; Zhang L; Herzog H; Voutetakis A; Baum BJ; Zolotukhin S, 2011, 'Salivary PYY: A putative bypass to satiety', PLoS One, 5, pp. Article no. e26137, http://dx.doi.org/10.1371/journal.pone.0026137

Painsipp E; Herzog H; Sperk G; Holzer P, 2011, 'Sex-dependent control of murine emotional-affective behaviour in health and colitis by peptide YY and neuropeptide y', British Journal of Pharmacology, 163, pp. 1302 - 1314, http://dx.doi.org/10.1111/j.1476-5381.2011.01326.x

Zhang L; Bijker MS; Herzog H, 2011, 'The neuropeptide y system: Pathophysiological and therapeutic implications in obesity and cancer', Pharmacology and Therapeutics, 131, pp. 91 - 113, http://dx.doi.org/10.1016/j.pharmthera.2011.03.011

Macia L; Rao PT; Wheway J; Sierro F; Mackay F; Herzog H, 2011, 'Y1 signalling has a critical role in allergic airway inflammation', Immunology and Cell Biology, 89, pp. 882 - 888, http://dx.doi.org/10.1038/icb.2011.6

Mountford J; Zhang L; Herzog H; Thompson P, 2010, 'Synthesis of Neuropeptide Y analogues as PET imaging agents', JOURNAL OF PEPTIDE SCIENCE, 16, pp. 89 - 89, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000281610800213&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Shi Y-C; Lin S; Wong IPL; Baldock PA; Aljanova A; Enriquez RF; Castillo L; Mitchell NF; Ye J-M; Zhang L; Macia L; Yulyaningsih E; Nguyen AD; Riepler SJ; Herzog H; Sainsbury A, 2010, 'NPY neuron-specific Y2 receptors regulate adipose tissue and trabecular bone but not cortical bone homeostasis in mice.', PLoS One, 5, pp. e11361, http://dx.doi.org/10.1371/journal.pone.0011361

Cox HM; Tough IR; Woolston A-M; Zhang L; Nguyen AD; Sainsbury A; Herzog H, 2010, 'Peptide YY is critical for acylethanolamine receptor Gpr119-induced activation of gastrointestinal mucosal responses.', Cell Metab, 11, pp. 532 - 542, http://dx.doi.org/10.1016/j.cmet.2010.04.014

Karl T; Chesworth R; Duffy L; Herzog H, 2010, 'Acoustic startle response and sensorimotor gating in a genetic mouse model for the NPY Y1 receptor.', Neuropeptides, 44, pp. 233 - 239

Zhang L; Lee NJ; Nguyen AD; Enriquez RF; Riepler SJ; Stehrer B; Yulyaningsih E; Lin S; Shi YC; Baldock PA; Herzog H; Sainsbury A, 2010, 'Additive actions of the cannabinoid and neuropeptide Y systems on adiposity and lipid oxidation.', Diabetes Obes Metab, 12, pp. 591 - 603, http://dx.doi.org/10.1111/j.1463-1326.2009.01193.x

Lin ED; Lin S; Aljanova A; During M; Herzog H, 2010, 'Adult-onset hippocampal-specific neuropeptide Y overexpression confers mild anxiolytic effect in mice', European Neuropsychopharmacology, 20, pp. 164 - 175

Purtell L; Sze L; Loughnan G; Smith E; Herzog H; Sainsbury A; Steinbeck K; Campbell LV; Viardot A, 2010, 'Critical role for ghrelin, but not PYY or GLP-1, in Prader–Willi syndrome hyperphagia', Obesity Research & Clinical Practice, 4, pp. S6 - S6, http://dx.doi.org/10.1016/j.orcp.2010.09.013

Painsipp E; Sperk G; Herzog H; Holzer P, 2010, 'Delayed stress-induced differences in locomotor and depression-related behaviour in female neuropeptide-Y Y1 receptor knockout mice', Journal of Psychopharmacology, 24, pp. 1541-9, http://dx.doi.org/10.1177/0269881109104851

Schwarzer C; Lutsch C; Schunk E; Kastenberger I; Herzog H, 2010, 'Endogenous dynorphin in emotional control and stress response revisited', BMC Pharmacology, 10, http://dx.doi.org/10.1186/1471-2210-10-s1-a32

Painsipp E; Herzog H; Holzer P, 2010, 'Evidence from knockout mice that neuropeptide-Y Y2 and Y4 receptor signalling prevents long-term depression-like behaviour caused by immune challenge', Journal of Psychopharmacology, 24, pp. 1551 - 1560

Wong IP; Baldock PA; Herzog H, 2010, 'Gastrointestinal peptides and bone health.', Curr Opin Endocrinol Diabetes Obes, 17, pp. 44 - 50, http://dx.doi.org/10.1097/MED.0b013e3283344a05

Yulyaningsih E; Macia L; Driesler F; Herzog H; Sainsbury A, 2010, 'Lack of Y6 receptor signaling in mice results in a lean phenotype on a chow diet but exacerbated high fat diet-induced obesity', Obesity Research & Clinical Practice, 4, pp. S65 - S65, http://dx.doi.org/10.1016/j.orcp.2010.09.127

Prior LJ; Purtell L; Duke S; Campbell L; Sainsbury A; Herzog H, 2010, 'Mouse model of Prader–Willi syndrome: The role of SNORD116 in the regulation of energy homeostasis', Obesity Research & Clinical Practice, 4, pp. S6 - S6, http://dx.doi.org/10.1016/j.orcp.2010.09.012

Zengin A; Zhang L; Herzog H; Baldock PA; Sainsbury A, 2010, 'Neuropeptide Y and sex hormone interactions in humoral and neuronal regulation of bone and fat.', Trends Endocrinol Metab, 21, pp. 411 - 418, http://dx.doi.org/10.1016/j.tem.2010.02.004

Tasan RO; Verma D; Herzog H; Sperk G, 2010, 'Neuropeptide Y in the basolateral amygdala modulates the acquisition of conditioned fear', BMC Pharmacology, 10, http://dx.doi.org/10.1186/1471-2210-10-s1-a33

Zhang L; Macia L; Turner N; Enriquez RF; Riepler SJ; Nguyen AD; Lin S; Lee NJ; Shi YC; Yulyaningsih E; Slack K; Baldock PA; Herzog H; Sainsbury A, 2010, 'Peripheral neuropeptide Y Y1 receptors regulate lipid oxidation and fat accretion.', Int J Obes (Lond), 34, pp. 357 - 373, http://dx.doi.org/10.1038/ijo.2009.232

Viardot AC; Sze L; Purtell L; Sainsbury-Salis A; Loughnan G; Smith E; Herzog H; Steinbeck K; Campbell LV, 2010, 'Prader-willi syndrome is associated with activation of the innate immune system independently of central adiposity and insulin resistance', Journal of Clinical Endocrinology and Metabolism, 95, pp. 3392 - 3399

Karl T; Chesworth R; Duffy L; Herzog H, 2010, 'Schizophrenia-relevant behaviours in a genetic mouse model for Y2 deficiency', Behavioural Brain Research, 207, pp. 434 - 440

Tasan R; Nguyen NK; Weger S; Sartori S; Singewald N; Heilbronn R; Herzog H; Sperk G, 2010, 'The central and basolateral amygdala are critical sites of neuropeptide Y/Y2 receptor-mediated regulation of anxiety and depression', Journal of Neuroscience, 30, pp. 6282 - 6290

Sainsbury A; Shi Y-C; Zhang L; Aljanova A; Lin Z; Nguyen AD; Herzog H; Lin S, 2010, 'Y4 receptors and pancreatic polypeptide regulate food intake via hypothalamic orexin and brain-derived neurotropic factor dependent pathways.', Neuropeptides, 44, pp. 261 - 268, http://dx.doi.org/10.1016/j.npep.2010.01.001

Lin S; Shi Y-C; Yulyaningsih E; Aljanova A; Zhang L; Macia L; Nguyen AD; Lin E-JD; During MJ; Herzog H; Sainsbury A, 2009, 'Critical role of arcuate Y4 receptors and the melanocortin system in pancreatic polypeptide-induced reduction in food intake in mice.', PLoS One, 4, pp. e8488, http://dx.doi.org/10.1371/journal.pone.0008488

Baldock PA; Lee NJ; Driessler F; Lin S; Allison S; Stehrer B; Lin E-JD; Zhang L; Enriquez RF; Wong IPL; McDonald MM; During M; Pierroz DD; Slack K; Shi YC; Yulyaningsih E; Aljanova A; Little DG; Ferrari SL; Sainsbury A; Eisman JA; Herzog H, 2009, 'Neuropeptide Y knockout mice reveal a central role of NPY in the coordination of bone mass to body weight.', PLoS One, 4, pp. e8415, http://dx.doi.org/10.1371/journal.pone.0008415

Allison SJ; Baldock PA; Enriquez R; Lin E; During M; Gardiner EM; Eisman JA; Sainsbury A; Herzog H, 2009, 'Critical interplay between neuropeptide Y and sex steroid pathways in bone and adipose tissue homeostasis', Journal of Bone and Mineral Research, 24, pp. 294 - 304

Nguyen NK; Sartori S; Herzog H; Tasan R; Sperk G; Singewald N, 2009, 'Effect of neuropeptide Y Y2 receptor deletion on emotional stress-induced neuronal activation in mice', Synapse, 63, pp. 236 - 246

Schwarzer C; Wittmann W; Schunk E; Kastenberger I; Gaburro S; Singewald N; Herzog H, 2009, 'Endogenous dynorphin in emotional control and stress response', BMC Pharmacology, 9, http://dx.doi.org/10.1186/1471-2210-9-s2-a39

Edelsbrunner M; Painsipp E; Herzog H; Holzer P, 2009, 'Evidence from knockout mice for distinct implications of neuropeptide-Y Y2 and Y4 receptors in the circadian control of locomotion, exploration, water and food intake', Neuropeptides, 43, pp. 491 - 497, http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19781771

Edelsbrunner M; Herzog H; Holzer P, 2009, 'Evidence from knockout mice that peptide YY and neuropeptide Y enforce murine locomotion, exploration and ingestive behaviour in a circadian cycle- and gender-dependent manner', Behavioural Brain Research, 203, pp. 97 - 107

Tasan R; Lin SC; Hetzenauer A; Singewald N; Herzog H; Sperk G, 2009, 'Increased novelty-induced motor activity and reduced depression-like behavior in neuropeptide Y (NPY)-Y4 receptor knockout mice', Neuroscience, 158, pp. 1717 - 1730

Kastenberger I; Schunk E; Herzog H; Schwarzer C, 2009, 'Involvement of dynorphin in anxiogenic effects of estrogen', BMC Pharmacology, 9, http://dx.doi.org/10.1186/1471-2210-9-s2-a9

Lee NJ; Herzog H, 2009, 'NPY regulation of bone remodelling.', Neuropeptides, 43, pp. 457 - 463, http://dx.doi.org/10.1016/j.npep.2009.08.006

Teixeira L; Sousa D; Nunes A; Sousa M; Herzog H; Lamghari M, 2009, 'NPY revealed as a critical modulator of osteoblast function in vitro: New insights into the role of Y1 and Y2 receptors', Journal of Cellular Biochemistry, 107, pp. 908 - 916

Sousa D; Herzog H; Lamghari M, 2009, 'NPY signalling pathway in bone homeostasis: Y1 receptor as a potential drug target', Current Drug Targets, 10, pp. 9 - 19

Wittmann W; Schunk E; Rosskothen I; Gaburro S; Singewald N; Herzog H; Schwarzer C, 2009, 'Prodynorphin-derived peptides are critical modulators of anxiety and regulate neurochemistry and corticosterone', Neuropsychopharmacology, 34, pp. 775 - 785

Painsipp E; Herzog H; Holzer P, 2009, 'The gut-mood axis: a novel role of the gut hormone peptide YY on emotional-affective behaviour in mice', BMC Pharmacology, 9, http://dx.doi.org/10.1186/1471-2210-9-s2-a13

Verma D; Tasan RO; Herzog H; Sperk G, 2009, 'The role of NPY in expression and extinction of conditioned fear', BMC Pharmacology, 9, http://dx.doi.org/10.1186/1471-2210-9-s2-a33

Tilan JU; Everhart LM; Abe K; Kitlinska J; Herzog H; Zukowska Z, 2008, 'Megakaryocyte/platelet-derived Neuropeptide Y (NPY), in addition to neuronal, is essential for ischemic revascularization in rodents', FASEB JOURNAL, 22, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208467808113&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Wong IPL; Zengin A; Herzog H; Baldock PA, 2008, 'Central regulation of bone mass', Seminars in Cell and Developmental Biology, 19, pp. 452 - 458, http://dx.doi.org/10.1016/j.semcdb.2008.08.001

Viardot AC; Heilbronn L; Herzog H; Gregersen S; Campbell LV, 2008, 'Abnormal postprandial PYY response in insulin sensitive nondiabetic subjects with a strong family history of type 2 diabetes', International Journal of Obesity and Related Metabolic Disorders, 32, pp. 943 - 948, http://dx.doi.org/10.1038/ijo.2008.24


Back to profile page